BridgeBio Pharma, Inc. Business Finance Contracts & Agreements

33 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Indenture, dated as of February 28, 2025, by and between BridgeBio Pharma, Inc. and U.S. Bank Trust Company, National Association, as Trustee
Indenture Agreements
BridgeBio Pharma, Inc.
Biotechnology
2025
Transaction Agreement, dated as of August 16, 2024, by and among BridgeBio Pharma, Inc., Viking Global Opportunities Illiquid Investments Sub-Master LP, Viking Global...
Investment Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2024
Underwriting Agreement, dated as of March 5, 2024, by and among the Company, J.P. Morgan Securities LLC, Cantor Fitzgerald & Co. and Mizuho Securities USA LLC, as representatives...
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2024
Registration Rights Agreement, dated September 25, 2023, by and among BridgeBio Pharma, Inc. and the purchasers party thereto
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Securities Purchase Agreement, dated September 25, 2023, by and among BridgeBio Pharma, Inc. and the purchasers party thereto
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2023
Form of Non-Qualified Stock Option Agreement under BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan (2023 Form)
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Form of Restricted Stock Award Agreement under BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan (2023 Form)
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Form of Restricted Stock Unit Award Agreement under BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan (2023 Form)
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Underwriting Agreement, dated as of March 7, 2023, by and among the Company, Goldman Sachs & Co. LLC, Evercore Group L.L.C. and Morgan Stanley & Co. LLC, as representatives of the...
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Loan and Security Agreement, among U.S. Bank National Association in its capacity as Administrative Agent and Collateral Agent, the Lenders party thereto, the Registrant, and...
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2022
Amended and Restated Employee Stock Purchase Plan
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Amended and Restated Employee Stock Purchase Plan
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Sixth Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of April 13, 2021
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Fifth Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of January 25, 2021
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Third Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of March 2, 2020
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Underwriting Agreement, dated as of February 11, 2021, by and among the Company, the Selling Stockholder and Goldman Sachs & Co. LLC, as the representative of the several...
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2021
Indenture, dated as of January 28, 2021, by and between BridgeBio Pharma, Inc. and U.S. Bank National Association, as Trustee
Indenture Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2021
Purchase Agreement, dated January 25, 2021, by and among BridgeBio Pharma, Inc. and J.P. Morgan Securities LLC and Mizuho Securities USA LLC, as representatives of the several...
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2021
Amended and Restated 2019 Employee Stock Purchase Plan, effective December 12, 2019
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2020
Indenture, dated as of March 9, 2020, by and between BridgeBio Pharma, Inc. and U.S. Bank National Association, as Trustee
Indenture Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2020
Purchase Agreement, dated March 4, 2020, by and among BridgeBio Pharma, Inc. and J.P. Morgan Securities LLC and BofA Securities, Inc., as representatives of the several Initial...
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2020
Loan and Security Agreement dated November 13, 2019 between Eidos Therapeutics, Inc., a partially owned subsidiary of Registrant, as borrower, Silicon Valley Bank and Hercules...
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Registration Rights Agreement
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
2019 Employee Stock Purchase Plan
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Form of Registration Rights Agreement, among the Registrant and certain of its shareholders, to be in effect immediately prior to completion of this offering
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Specimen Common Stock Certificate
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
2019
Form of Underwriting Agreement
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2019
Second Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital Inc., dated as of May 17, 2019
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Asset Purchase Agreement, among Phoenix Tissue Repair, Inc., Shire Human Genetic Therapies, Inc., and Lotus Tissue Repair, Inc., dated as of July 21, 2017
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2019
Asset Purchase Agreement, among BridgeBio Pharma LLC, Origin Biosciences, Inc., and Alexion Pharma Holding Unlimited Company, dated as of June 7, 2018
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
First Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of December 28, 2018
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of June 19, 2018
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Form of Registration Rights Agreement, among the Registrant and certain of its shareholders, to be in effect immediately prior to completion of this offering
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019